Clinical research reactivation during the COVID-19 pandemic: An academic center process and lessons for the future.

ABSTRACT:

Background

Clinical research is a central mission of the University of Colorado Anschutz Medical Campus (CU-Anschutz). On March 18, 2020, due to rising COVID-19 rates and personal protective equipment (PPE) shortages, an emergency approval process for critical research essential to the care and safety of patients, including COVID-19 trials, was enacted. All other clinical research studies requiring face-to-face visits were placed on hold to protect participant and staff safety.

Methods

A clinical research TaskForce was rapidly assembled, consisting of a cross- section of campus clinical research operations leaders, including affiliate hospitals. This group developed a guidance document and process where the primary prioritization factor was positive therapeutic benefit/risk

SUBMITTER: Armstrong J 

PROVIDER: S-EPMC10139738 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature